Fangfang Wang

TLR7-expressing cells comprise an interfollicular epidermal stem cell population in murine epidermis.

Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy.

PIG7 promotes leukemia cell chemosensitivity via lysosomal membrane permeabilization.

Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.

A Cross-sectional Survey of Growth and Nutritional Status in Children With Cerebral Palsy in West China.

IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis.

Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.

RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy.

[Correlation Between Gross Motor Function and Risk Factors in Children with Cerebral Palsy:an Epidemiology Study in Chengdu].

[Advances in genetic research of cerebral palsy].

[Report of a case with 14q12 triplication and literature review for FOXG1 related diseases].

Nutlin-3 plus tanshinone IIA exhibits synergetic anti-leukemia effect with imatinib by reactivating p53 and inhibiting the AKT/mTOR pathway in Ph+ ALL.

Young female patients with multiple myeloma have low occurrence of osteolytic lesion.

Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34 cells.

SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia.

[Molecular Characteristics and Clinical Features of Adults with Fusions in Acute Myeloid Leukemia].

The combination of Nutlin-3 and Tanshinone IIA promotes synergistic cytotoxicity in acute leukemic cells expressing wild-type p53 by co-regulating MDM2-P53 and the AKT/mTOR pathway.

Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for "on-demand" drug delivery.

Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.

PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells.

An impact assessment of energy undesirable output on climate-carrying capacity: a case study of Shanghai.

SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p.

Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.

Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China.

BMI1 regulates multiple myeloma-associated macrophage's pro-myeloma functions.

Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.

Cerebral palsy in children born after assisted reproductive technology: a meta-analysis.

Alteration of immune profiles is associated with pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.

ALCAM-EGFR interaction regulates myelomagenesis.

Minimal residual disease in multiple myeloma: current status.

Tanshinone IIA potentiates the efficacy of imatinib by regulating the AKT-MDM2-P53 signaling pathway in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Cancer-Cell-Biomimetic Nanoparticles for Targeted Therapy of Multiple Myeloma Based on Bone Marrow Homing.

Estrogen-Responsive Gene MAST4 Regulates Myeloma Bone Disease.

ALCAM regulates multiple myeloma chemoresistant side population.

Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemia.

ISG20L2 suppresses bortezomib antimyeloma activity by attenuating bortezomib binding to PSMB5.

A novel immune prognostic model of non-M3 acute myeloid leukemia.

A stratified therapeutic model incorporated with studies on regulatory B cells for elderly patients with newly diagnosed multiple myeloma.

Donor peritoneal-derived cells can attenuate graft-versus-host disease after MHC-incompatible bone marrow transplantation in mice.

Erratum: Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Erratum.

Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity.

Combinations of ivermectin with proteasome inhibitors induce synergistic lethality in multiple myeloma.

: a probiotic for the prevention and treatment of depression.

Umbilical cord-derived mesenchymal stem cells cultured in the MCL medium for aplastic anemia therapy.

Methylcrotonyl-CoA carboxylase subunit 1 (MCCA) regulates multidrug resistance in multiple myeloma.

RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexor.

AMPK-upregulated microRNA-708 plays as a suppressor of cellular senescence and aging via downregulating disabled-2 and mTORC1 activation.

Decreased RNA-binding protein heterogeneous nuclear ribonucleoprotein U improves multiple myeloma sensitivity to lenalidomide.

Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia.

Single-cell sequencing reveals the correlation of aggrephagy signaling and multiple myeloma immune microenvironment composition.